| Ytd | -1.29% | |
| 1y | -51.82% |
| Open | 3.77 | Prev Close | 3.76 | Low | 3.77 | High | 3.88 | Mkt Cap | 20.70M |
| Vol | 8.91K | Avg Vol | 200.60K | EPS | -11.06 | P/E | -0.35 | Forward P/E | N/A |
| Beta | 0.75 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-17 | 50-d Avg | 3.97 | 200-d Avg | 4.34 | 1yr Est | 0.00 |
Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regula
Scancell Holdings plc (AIM: SCLP) ("Scancell") and Neuphoria Therapeutics Inc. (NASDAQ:NEUP)